Neurogenetics Branch, National Institute of Neurological Disorders and Stroke/NIH, Bethesda, MD 20892, USA.
Mol Genet Metab. 2011 Feb;102(2):207-9. doi: 10.1016/j.ymgme.2010.10.002. Epub 2010 Oct 28.
Unrelated umbilical cord blood transplantation (UCBT) was used to treat three siblings with juvenile metachromatic leukodystrophy (jMLD). The efficacy of this therapy was measured over a 5-year period with serial neurological examinations, neuroimaging, nerve conduction studies (NCS), and neuropsychological evaluations (NPE). Outcomes were a function of disease stage at time of UCBT with alteration of disease course occurring in the first 2 years after UCBT and then subsequent halting of progression and stabilization of symptoms and disease.
采用非亲缘脐带血移植(UCBT)治疗了 3 名患有幼年型黏脂贮积症(jMLD)的同胞。通过连续的神经学检查、神经影像学、神经传导研究(NCS)和神经心理学评估(NPE),对该治疗的疗效进行了 5 年的评估。移植时疾病阶段是影响结果的关键因素,UCBT 后 2 年内疾病进程发生改变,随后疾病进展停止,症状和疾病稳定。